Browse result page of CPPsite 2.0
The total number entries retrieved from this search are 31| ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 | rrrrrrrrrcqcrrkn | R9-GO-203 | 16 | D | Linear | Synthetic | Cationic | Free | Free | NA | Small molecule drug (Taxol and doxorubicin) | 23114713 |
| 2008 | RWRWRWRW | (RW)4 | 8 | L | Linear | Synthetic | Cationic | Free | Free | Drug conjugated with peptide through linker | Small molecule drug (Doxorubicin) | 23301519 |
| 2009 | WRWKKKKA | cyclic [W(RW)4] | 8 | L | Cyclic | Synthetic | Cationic | NA | NA | Drug conjugated with peptide through linker | Small molecule drug (Doxorubicin) | 23301519 |
| 2018 | CRNGRGPDC | iNGR | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2019 | CNGRC | NGR | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2020 | CRGDC | RGD | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2021 | CRGDKGDPC | iRGD | 9 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin) and Fluorophore (FAM) | 23151901 |
| 2043 | CLLIILRRRIRKQAHAHSKNHQQQNPHQPPM | Dox-pVEC-gHo (Dox- gHoPe2) | 31 | L | Linear | Synthetic | NA | Succinimidyl-4-(N-mal-eimidomethyl) cyclohexane-1-carboxylate (SMCC) | Amidation | NA | Small molecule drug (Doxorubicin) | 23350661 |
| 2098 | CRGDK | CRGDK | 5 | L | Linear | Synthetic | NA | Free | Free | NA | Small molecule drug (Doxorubicin), DSPE- PEG2000 | 23634882 |
| 2121 | YGRKKRRQRRR | TAT | 11 | L | Linear | Protein derived | NA | Free | NA | NA | Small molecule drug (Doxorubicin and Paclitaxel) | 23792465 |
| 2345 | RRRRR | Arg5-ELPBC | 5 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
| 2346 | RRRRRRRR | Arg8-ELPBC | 8 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
| 2347 | YGRKKRRQRRR | TAT-ELPBC | 11 | L | Linear | Protein derived | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
| 2348 | YGRGGRRGRRR | RTAT-ELPBC | 11 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
| 2443 | HEHEHEHEHE-PEG-PLA | HEO | 10 | L | Linear | Synthetic | Cationic | Free | Conjugation with PEG-PLA | NA | Fluorophore (Coumarin-6) and small molecule drug (Docetaxel) | 24614579 |
| 2444 | RGRGRGRGRG-PEG-PLA | RGO | 10 | L | Linear | Synthetic | Cationic | Free | Conjugation with PEG-PLA | NA | Fluorophore (Coumarin-6) and small molecule drug (Docetaxel) | 24614579 |
| 2445 | mPEG-PLA-HEHEHEHEHE | HEI | 10 | L | Linear | Synthetic | Cationic | Conjugated with PEG-PLA | Free | NA | Fluorophore (Coumarin-6) and small molecule drug (Docetaxel) | 24614579 |
| 2446 | mPEG-PLA-RGRGRGRGRG | RGI | 10 | L | Linear | Synthetic | Cationic | Conjugated with PEG-PLA | Free | NA | Fluorophore (Coumarin-6) and small molecule drug (Docetaxel) | 24614579 |
| 2470 | VSRRRRRRGGRRRR | C24-LMWP | 14 | L | Linear | Protein derived | Cationic | Free | Free | NA | Nanoparticle (LMWP/PLGA nanoparticles), Small molecule drug (Doxorubicin) | 25003794 |
| 2477 | CGRKKRRQRRRPPQ | NTD | 14 | L | Linear | Protein derived | Cationic | Acetylation | Amidation | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). | Small molecule drug (Doxorubicin) | 24892976 |
| 2478 | KGRKKRRQRRRPPQ | d-NTD | 14 | L | Linear | Protein derived | Cationic | Acetylation | Amidation | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). | Small molecule drug (Doxorubicin) | 24892976 |
| 2479 | KGRKKRRQRRRPPQ | q-NTD | 14 | L | Linear | Protein derived | Cationic | Acetylation | Amidation | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). | Small molecule drug (Doxorubicin) | 24892976 |
| 2480 | CGRKKRRQRRRPPQ | n-NTD | 14 | L | Linear | Protein derived | Cationic | Acetylation | Amidation | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). | Small molecule drug (Doxorubicin) | 24892976 |
| 2481 | CGRKKRRQRRRPPQ | C16NTD | 14 | L | Linear | Protein derived | Cationic | Palmitoylation | Amidation | Doxorubicin is attached by a cathepsin B degradable tetrapeptide linker (-Gly-Phe-Leu-Gly-). | Small molecule drug (Doxorubicin) | 24892976 |
| 2514 | RKKRRQRRRRKKRRQRRR | Tat2-Nat | 18 | L | Linear | Protein derived | Cationic | Conjugation with FITC | Conjugation with natamycin | NA | Small molecule drug (Natamycin), Fluorophore (FITC) | 25467959 |
| 2515 | AKKRRQRRRAKKRRQRRR | MTat2-Nat | 18 | L | Linear | Synthetic | Cationic | Conjugation with FITC | Conjugation with natamycin | NA | Small molecule drug (Natamycin), Fluorophore (FITC) | 25467959 |
| 2584 | AYGRKKRRQRRR | DOX-TAT-LIP | 12 | L | Linear | Protein derived | Cationic | Cysteine addition | Free | NA | Nanaoparticle (Liposome), Small molecule drug (Doxorubicin) | 24893333 |
| 2585 | AYGRKKRRQRRR | DOX-T7-TAT-LIP | 12 | L | Linear | Protein derived | Cationic | Cysteine addition | Free | NA | Nanoparticle (Liposome), Small molecule drug (Doxorubicin), protein (Transferin) | 24893333 |
| 2589 | GRKKRRQRRRPPQ | HIV-TAT | 13 | L | Linear | Protein derived | Cationic | Free | Free | NA | Sodium diclofenac (Na-DFC), Small molecule drug [celecoxib (CLXB)] | 24798650 |
| 2672 | rrrrrrrrGC | r8 | 10 | D | Linear | Synthetic | Cationic | NA | Amidation | NA | Fluorophore (Alexa660), Small molecule drug (doxorubicin) | 22285548 |
| 2719 | GLWWKAWWKAWWKSLWWRKRKRKA | CADY-1 | 24 | L | Linear | Synthetic | Amphipathic | NA | NA | NA | Small molecule drug (Doxorubicin) | 22688249 |